—— PARTNERS & INVESTORS

Become part of our journey

Tzu works with pharma and biotech companies, clinical and research centers, and investors. Contact us for further inquiries.

—— PHARMA & BIOTECH

Pharma partnering with TzuPlus technology

01

Improving early drug
evaluation

Measurement of target expression and resistance mechanisms in clinical evaluation.

02

Target identification and validation in pre-treated metastatic disease

Target expression data in pre-treated, actively metastasizing disease.

​

03

Patient stratification

Stratification based on CTC target expression, with the potential to improve overall response rates in pre-selected cohorts.

—— CLINICAL & RESEARCH CENTERS

Clinical and research collaboration with Tzu

01

Sample collection

Leukapheresis and blood tube sampling of cancer patients.

02

Patient inclusion

Inclusion of patients in sampling studies, with feedback on patient experience and clinical impact.

03

Research Collaboration

Joint technology and research projects, such as the Eurostars project on automated antigen identification.

Upcoming Events

At Tzu Cancer Therapeutics, we are committed to sharing knowledge and actively engaging with the oncology and scientific communities.

01

02

Conference | SITC

November 4-8, 2026 - Phoenix, US

03

Conference | BIO Europe

November 9-11, 2026 - Cologne, Germany

Conference | Jefferies Global Healthcare

November 17-20, 2026 - London, UK

Past Events

01

02

03

Conference | EACR Liquid Biopsies

September 22-24, 2026 - Lyon, France

Congress | EACR Innovative Cancer Science

June 08-11, 2026 - Budapest, Hungary

Convention | BIO International

June 22-25, 2026 - San Diego, USA

CONTACT

Talk to our CBO

Partnership conversations are led by Dr. Mike Shaw, Chief Business Officer at Tzu Cancer Therapeutics.

OPEN APPLICATION

Become part of Team Tzu